Cited by — Baseline Serum Albumin-to-Creatinine Ratio as an Independent Prognostic Marker in De Novo Metastatic HER2-negative Gastric Cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Baseline Serum Albumin-to-Creatinine Ratio as an Independent Prognostic Marker in De Novo Metastatic HER2-negative Gastric Cancer.
No admitted local citation edges point to this work yet.
